ASH Clinical News ACN_4.1_FULL_ISSUE_DIGITAL | Page 44

Literature Scan In this study, a computer-based e-alert system automatically identified adult patients hospitalized at the University Hospital in Bern who were not receiving anticoagulation. Patients were randomized 1:1 to either the e-alert group (n=804; in which an alert and the Geneva Risk Score calculation tool were issued directly in the electronic patient chart) or the control group (n=789; in which no alert was issued). The Geneva Risk Score calculates a patient’s risk for VTE on a scale of one to 22 (22 representing highest risk for VTE), ac- counting for age, history of VTE, surgery, active malignancy, and other factors that might raise VTE risk. Patients were hospitalized for a me- dian of six days (range = 4-10 days), and patient characteristics and reasons for hospital admission (most commonly non- pulmonary infection and acute stroke) were similar between each group. The e-alert system pop-up screen first asked the physician to complete the Geneva Risk Score. The system permit- ted physicians to postpone this action three times (an allowance to help increase compliance); once the physician agreed to calculate the Geneva Risk Score, the system generated the total. If the risk score was ≥3 points, the e-alert system informed the physician that thromboprophylaxis was indicated, listing detailed recommendations for specific anticoagulants (enoxaparin or unfraction- ated heparin) or mechanical measures (compression stockings or intermittent pneumatic compression), depending on a patient’s bleeding risk. Thromboprophy- laxis was not indicated for patients with a Geneva Risk Score <3 points. Research nurses also reviewed patient records to gather data on baseline demo- graphics, comorbid conditions, laboratory